已收盤 11-06 16:00:00 美东时间
+0.080
+1.14%
11月7日,Solaris Resources(SLSR)收涨1.14%,报7.09美元,成交额133.84万美元,市值11.85亿美元。 行情数据 • 开盘价...
11-07 06:38
10月31日,Solaris Resources(SLSR)收跌4.8%,报6.55美元,成交额633.14万美元,市值10.94亿美元。 行情数据 • 开盘价...
10-31 05:42
10月27日,Solaris Resources(SLSR)收涨0.9%,报6.71美元,成交额68.02万美元,市值11.21亿美元。 行情数据 • 开盘价...
10-27 05:43
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:44
Solaris Resources Inc. reports progress on its Warintza copper project in Ecuador, including renewed agreements with Indigenous organizations, finalized community life plans recognizing mining's role in development, technical approval of the Environmental Impact Assessment, advancing permitting processes, and ongoing technical studies. The company also highlights strong financial backing, supporting the project's next development phase.
09-10 11:00
Mining financier Frank Giustra is warning of a structural paradigm shift across global commodities. After 45 years of experience financing the sector, he sees copper facing a severe supply shortage just as gold is being repriced as protection against sovereign debt and currency debasement. "Copper i...
07-14 18:23
Solaris Resources Inc. held its annual shareholders' meeting on June 30, 2026, in Quito, Ecuador. All matters presented for approval were successfully passed, including the election of five directors, the appointment of BDO Canada LLP as auditors, and the ratification of unallocated stock option plan entitlements. The results showed strong support for each proposal, with high vote percentages for directors and nearly 100% approval for auditors an...
06-30 20:00
Shares of precious-metals related companies are trading lower as rising Treasur...
05-16 00:57
Issued on behalf of Salazar Resources Ltd. VANCOUVER, BC, May 8, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — The global copper market just flipped from surplus to deficit, and th...
05-08 22:19
今日重点评级关注:HC Wainwright & Co.:维持Solaris Resources"买入"评级,目标价从16美元升至18美元;Leerink Partners:维持Spyre Therapeutics"跑赢大市"评级,目标价从49美元升至106美元
04-14 10:44